Citations (160)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Srinivas Kamath, Andrea M. Stringer, Clive A. Prestidge & Paul Joyce. (2023) Targeting the gut microbiome to control drug pharmacomicrobiomics: the next frontier in oral drug delivery. Expert Opinion on Drug Delivery 20:10, pages 1315-1331.
Read now
Read now
Amina Džidić-Krivić, Jasna Kusturica, Emina Karahmet Sher, Nejra Selak, Nejra Osmančević, Esma Karahmet Farhat & Farooq Sher. (2023) Effects of intestinal flora on pharmacokinetics and pharmacodynamics of drugs. Drug Metabolism Reviews 55:1-2, pages 126-139.
Read now
Read now
Filipa Leal, Scarlett Zeiringer, Ramona Jeitler, Pedro F. Costa & Eva Roblegg. (2023) A comprehensive overview of advanced dynamic in vitro intestinal and hepatic cell culture models. Tissue Barriers 0:0.
Read now
Read now
Moamen M. Elmassry, Ahmed Zayed & Mohamed A. Farag. (2022) Gut homeostasis and microbiota under attack: impact of the different types of food contaminants on gut health. Critical Reviews in Food Science and Nutrition 62:3, pages 738-763.
Read now
Read now
Lenka Jourova, Pavel Anzenbacher, Zuzana Matuskova, Rostislav Vecera, Jan Strojil, Milan Kolar, Milan Nobilis, Petra Hermanova, Tomas Hudcovic, Hana Kozakova, Miloslav Kverka & Eva Anzenbacherova. (2019) Gut microbiota metabolizes nabumetone in vitro: Consequences for its bioavailability in vivo in the rodents with altered gut microbiome. Xenobiotica 49:11, pages 1296-1302.
Read now
Read now
Aleksandra Tarasiuk & Jakub Fichna. (2019) Gut microbiota: what is its place in pharmacology?. Expert Review of Clinical Pharmacology 12:10, pages 921-930.
Read now
Read now
Rodney R. Dietert. (2017) Safety and risk assessment for the human superorganism. Human and Ecological Risk Assessment: An International Journal 23:8, pages 1819-1829.
Read now
Read now
Articles from other publishers (153)
Mohammad Umar Khan, Parakh Basist, Gaurav, Sultan Zahiruddin, Naveen Reddy Penumallu & Sayeed Ahmad. (2024) Ameliorative effect of traditional polyherbal formulation on TNF-α, IL-1β and Caspase-3 expression in kidneys of wistar rats against sodium fluoride induced oxidative stress. Journal of Ethnopharmacology 318, pages 116900.
Crossref
Crossref
Bing Ma, Samuel J. Gavzy, Michael France, Yang Song, Hnin Wai Lwin, Allison Kensiski, Vikas Saxena, Wenji Piao, Ram Lakhan, Jegan Iyyathurai, Lushen Li, Christina Paluskievicz, Long Wu, Marina WillsonShirkey, Emmanuel F. Mongodin, Valeria R. Mas & Jonathan S. Bromberg. (2023) Rapid intestinal and systemic metabolic reprogramming in an immunosuppressed environment. BMC Microbiology 23:1.
Crossref
Crossref
George Lagoumintzis & George P. Patrinos. (2023) Triangulating nutrigenomics, metabolomics and microbiomics toward personalized nutrition and healthy living. Human Genomics 17:1.
Crossref
Crossref
Xiaoyan Liu, Rui Zhang, Rong Li, Qiong Wu, Chao Pan, Xiangqing Yu, Yuhui Liu, Benjie Wang & Shuwen Yu. (2023) Safety, tolerability, and pharmacokinetics of ibrexafungerp in healthy Chinese subjects: a randomized, double-blind, placebo-controlled phase 1 trial. Antimicrobial Agents and Chemotherapy.
Crossref
Crossref
Anton S. Kolodnitsky, Nikita S. Ionov, Anastasia V. Rudik, Dmitry A. Filimonov & Vladimir. V. Poroikov. (2023) HGMMX: Host Gut Microbiota Metabolism Xenobiotics Database. Journal of Chemical Information and Modeling 63:21, pages 6463-6468.
Crossref
Crossref
Samradhi Singh, Devojit Kumar Sarma, Vinod Verma, Ravinder Nagpal & Manoj Kumar. (2023) Unveiling the future of metabolic medicine: omics technologies driving personalized solutions for precision treatment of metabolic disorders. Biochemical and Biophysical Research Communications 682, pages 1-20.
Crossref
Crossref
Ruolin Li, Fereshteh Shokri, Alejandro Lopez Rincon, Fernando Rivadeneira, Carolina Medina-Gomez & Fariba Ahmadizar. (2023) Bi-Directional Interactions between Glucose-Lowering Medications and Gut Microbiome in Patients with Type 2 Diabetes Mellitus: A Systematic Review. Genes 14:8, pages 1572.
Crossref
Crossref
Khaled Naja, Najeha Anwardeen, Moustafa Al-Hariri, Asmaa A. Al Thani & Mohamed A. Elrayess. (2023) Pharmacometabolomic Approach to Investigate the Response to Metformin in Patients with Type 2 Diabetes: A Cross-Sectional Study. Biomedicines 11:8, pages 2164.
Crossref
Crossref
Vinoth Kumarasamy, Umah Rani Kuppusamy, Pailoor Jayalakshmi & Suresh Kumar Govind. (2023) Blastocystis sp. reduces the efficacy of 5-fluorouracil as a colorectal cancer chemotherapeutic treatment. Experimental Parasitology 251, pages 108564.
Crossref
Crossref
Machel Leuschner & Allan Duncan Cromarty. (2023) Critical Assessment of Phenotyping Cocktails for Clinical Use in an African Context. Journal of Personalized Medicine 13:7, pages 1098.
Crossref
Crossref
Hao-Jian Zhang, Yan Wang & Jian-Dong Jiang. (2023) Drug-gut Microbiome Interaction in Atherosclerosis Therapeutics. Current Drug Metabolism 24:7, pages 482-492.
Crossref
Crossref
Chrisna Matthee, Andrew Ross Brown, Anke Lange & Charles R. Tyler. (2023) Factors Determining the Susceptibility of Fish to Effects of Human Pharmaceuticals. Environmental Science & Technology 57:24, pages 8845-8862.
Crossref
Crossref
Suyin Feng, Quan Wan, Weijiang Wu, Chenyang Zhang, Hua Lu & Xiaojie Lu. (2023) Effect of gut microbiome regulated Taohong Siwu Decoction metabolism on glioma cell phenotype. Frontiers in Cellular and Infection Microbiology 13.
Crossref
Crossref
Maja Hitl, Snežana Brkić & Nebojša Kladar. (2023) In vitro fermentation of rosmarinic acid and lemon balm (Melissa officinalis L., Lamiaceae) extract by probiotic microorganisms. South African Journal of Botany 157, pages 251-257.
Crossref
Crossref
Mingxue Gao, Hongwei Tu, Penghong Liu, Yanyan Zhang, Ruiyu Zhang, Lin Jing & Kerang Zhang. (2023) Association analysis of gut microbiota and efficacy of SSRIs antidepressants in patients with major depressive disorder. Journal of Affective Disorders 330, pages 40-47.
Crossref
Crossref
Grace Hey, Navya Nair, Emily Klann, Anjela Gurrala, Delaram Safarpour, Volker Mai, Adolfo Ramirez-Zamora & Vinata Vedam-Mai. (2023) Therapies for Parkinson’s disease and the gut microbiome: evidence for bidirectional connection. Frontiers in Aging Neuroscience 15.
Crossref
Crossref
Xin Tao, Wenjin Huang, Lingyun Pan, Lili Sheng, Yuan Qin, Luo Chen, Linhuan Yu, Gaosong Wu, Jianbo Wan & Houkai Li. (2023) Optimizing ex vivo culture conditions to study human gut microbiome. ISME Communications 3:1.
Crossref
Crossref
Liyang Jia, Shiqiong Huang, Boyu Sun, Yongguang Shang & Chunsheng Zhu. (2023) Pharmacomicrobiomics and type 2 diabetes mellitus: A novel perspective towards possible treatment. Frontiers in Endocrinology 14.
Crossref
Crossref
Suraphan Panyod, Wei-Kai Wu, Chieh-Chang Chen, Ming-Shiang Wu, Chi-Tang Ho & Lee-Yan Sheen. (2023) Modulation of gut microbiota by foods and herbs to prevent cardiovascular diseases. Journal of Traditional and Complementary Medicine 13:2, pages 107-118.
Crossref
Crossref
V. T. Anju, Siddhardha Busi, Mahima S. Mohan & Madhu Dyavaiah. 2023. Probiotics, Prebiotics, Synbiotics, and Postbiotics. Probiotics, Prebiotics, Synbiotics, and Postbiotics
117
138
.
Maja Đanić, Slavica Lazarević, Nebojša Pavlović, Bojan Stanimirov & Momir Mikov. (2022) Gut microbiota metabolism and bioaccumulation of drugs. Macedonian Pharmaceutical Bulletin 68:03, pages 543-544.
Crossref
Crossref
Filip Djokoski & Marija Hiljadnikova-Bajro. (2022) Novel insights in pharmacomicrobiomics. Macedonian Pharmaceutical Bulletin 68:03, pages 353-354.
Crossref
Crossref
Zhiyan Wang, Chengqian Hou, Lei Chen, Mingming Zhang & Wenbo Luo. (2022) Potential roles of the gut microbiota in the manifestations of drug use disorders. Frontiers in Psychiatry 13.
Crossref
Crossref
Imran Khan, Mohammad Hassan Baig, Sadaf Mahfooz, Mohammad Azhar Imran, Mohd Imran Khan, Jae-June Dong, Jae Yong Cho & Mustafa Aziz Hatiboglu. (2022) Nanomedicine for glioblastoma: Progress and future prospects. Seminars in Cancer Biology 86, pages 172-186.
Crossref
Crossref
Ping Zhong, Jing Zhou, Yan-Ting Fan, Meng-Fei Guo, He Zhu, Shan-Shan Zhou, Jin-Hao Zhu, Huan-Huan Zhang, Gui-Rong Zhou, Xing-Long Miao, Song-Lin Li & Qian Mao. (2022) Co-existing polysaccharides affect the systemic exposure of major bioactive ingredients in Chang-Kang-Fang, a multi-herb prescription for treatment of irritable bowel syndrome. Journal of Ethnopharmacology 298, pages 115601.
Crossref
Crossref
Pei-Jun Ma, Meng-Meng Wang & Yun Wang. (2022) Gut microbiota: A new insight into lung diseases. Biomedicine & Pharmacotherapy 155, pages 113810.
Crossref
Crossref
Junbo Zhu, Yabin Duan, Delong Duo, Jianxin Yang, Xue Bai, Guiqin Liu, Qian Wang, Xuejun Wang, Ning Qu, Yang Zhou & Xiangyang Li. (2022) High-altitude Hypoxia Influences the Activities of the Drug-Metabolizing Enzyme CYP3A1 and the Pharmacokinetics of Four Cardiovascular System Drugs. Pharmaceuticals 15:10, pages 1303.
Crossref
Crossref
Angelica Varesi, Lucrezia Irene Maria Campagnoli, Foroogh Fahmideh, Elisa Pierella, Marcello Romeo, Giovanni Ricevuti, Marchesi Nicoletta, Salvatore Chirumbolo & Alessia Pascale. (2022) The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment. International Journal of Molecular Sciences 23:20, pages 12289.
Crossref
Crossref
Xue Bai, Jianxin Yang, Guiqin Liu, Junbo Zhu, Qian Wang, Wenqi Gu, Linli La & Xiangyang Li. (2022) Regulation of CYP450 and drug transporter mediated by gut microbiota under high-altitude hypoxia. Frontiers in Pharmacology 13.
Crossref
Crossref
Le Liu, Yuping Bai, Lin Xiang, Wenbo Qi, Lei Gao, Xiaomei Li, Haiyuan Li, Bofang Wang & Hao Chen. (2022) Interaction between gut microbiota and tumour chemotherapy. Clinical and Translational Oncology 24:12, pages 2330-2341.
Crossref
Crossref
Josephine H. Li & Jose C. Florez. (2022) On the Verge of Precision Medicine in Diabetes. Drugs 82:13, pages 1389-1401.
Crossref
Crossref
Nicolas Lanthier & Nathalie Delzenne. (2022) Targeting the Gut Microbiome to Treat Metabolic Dysfunction-Associated Fatty Liver Disease: Ready for Prime Time?. Cells 11:17, pages 2718.
Crossref
Crossref
Massimiliano Marazzato, Cristina Iannuccelli, Maria Paola Guzzo, Lucia Nencioni, Bruno Lucchino, Giulia Radocchia, Chiara Gioia, Giulia Bonfiglio, Bruna Neroni, Francesca Guerrieri, Fabrizio Pantanella, Stefania Garzoli, Marta Vomero, Cristiana Barbati, Manuela Di Franco & Serena Schippa. (2022) Gut Microbiota Structure and Metabolites, Before and After Treatment in Early Rheumatoid Arthritis Patients: A Pilot Study. Frontiers in Medicine 9.
Crossref
Crossref
Hang Yu, Jie Fu, Hui-Hui Guo, Li-Bin Pan, Hui Xu, Zheng-Wei Zhang, Jia-Chun Hu, Xin-Yu Yang, Hao-Jian Zhang, Meng-Meng Bu, Yuan Lin, Jian-Dong Jiang & Yan Wang. (2022) Metabolites Analysis of Anti-Myocardial Ischemia Active Components of Saussurea involucrata Based on Gut Microbiota—Drug Interaction. International Journal of Molecular Sciences 23:13, pages 7457.
Crossref
Crossref
Yousuf Mohammed, Amy Holmes, Philip Chi Lip Kwok, Tushar Kumeria, Sarika Namjoshi, Mohammad Imran, Lana Matteucci, Masood Ali, Waiting Tai, Heather A.E. Benson & Michael S. Roberts. (2022) Advances and future perspectives in epithelial drug delivery. Advanced Drug Delivery Reviews 186, pages 114293.
Crossref
Crossref
Ifeoma Julieth Dikeocha, Abdelkodose Mohammed Al‐Kabsi, Muhammad Miftahussurur & Mohammed Abdullah Alshawsh. (2022) Pharmacomicrobiomics: Influence of gut microbiota on drug and xenobiotic metabolism. The FASEB Journal 36:6.
Crossref
Crossref
Jiayu Ma, Xiangshu Piao, Shad Mahfuz, Shenfei Long & Jian Wang. (2022) The interaction among gut microbes, the intestinal barrier and short chain fatty acids. Animal Nutrition 9, pages 159-174.
Crossref
Crossref
Zezhen Wu, Yongru Chen, Dan Zhu, Yingmiao Zheng, Khan Barkat Ali & Kaijian Hou. (2022) Advancement of Traditional Chinese Medicine in Regulation of Intestinal
Flora: Mechanism-based Role in Disease Management. Recent Patents on Anti-Cancer Drug Discovery 17:2, pages 136-144.
Crossref
Crossref
Moaz A. Al-Gham, Othman A. Baothma, Muhammad Afzal, Sami I. Alzarea, Firoz Anwar, Muhammad Shahid Nad & Imran Kazmi. (2022) Levonorgestrel and Desogestrel Modulate Gut Microbiota and Blood Biochemistry of Female Wistar Rats. International Journal of Pharmacology 18:4, pages 826-841.
Crossref
Crossref
Negin ALMASİ, Arzu KABASAKAL ÇETİN & Zeynep GÖKTAŞ. (2022) Anoreksiya Nervosalı Hastalarda İntestinal Mikrobiyotanın RolüRole of Intestinal Microbiota in Patients with Anorexia Nervosa. Psikiyatride Güncel Yaklaşımlar 14:1, pages 65-73.
Crossref
Crossref
Giandomenico Roviello, Luigi Francesco Iannone, Melissa Bersanelli, Enrico Mini & Martina Catalano. (2022) The gut microbiome and efficacy of cancer immunotherapy. Pharmacology & Therapeutics 231, pages 107973.
Crossref
Crossref
Suqing Zheng, Lei Wang, Jun Xiong, Guang Liang, Yong Xu & Fu Lin. (2022) Consensus Prediction of Human Gut Microbiota-Mediated Metabolism Susceptibility for Small Molecules by Machine Learning, Structural Alerts, and Dietary Compounds-Based Average Similarity Methods. Journal of Chemical Information and Modeling 62:4, pages 1078-1099.
Crossref
Crossref
Alistair Victor William Nunn, Geoffrey William Guy & Jimmy David Bell. (2022) Thermodynamics and Inflammation: Insights into Quantum Biology and Ageing. Quantum Reports 4:1, pages 47-74.
Crossref
Crossref
Yukuang Guo, Shaofei Ji, Wei Wang, Susan Wong, Chun-Wan Yen, Chloe Hu, Dennis H. Leung, Emile Plise, Shu Zhang, Chenghong Zhang, Uchenna A. Anene, Donglu Zhang, Christian N. Cunningham, S. Cyrus Khojasteh & Dian Su. (2022) An Integrated Strategy for Assessing the Metabolic Stability and Biotransformation of Macrocyclic Peptides in Drug Discovery toward Oral Delivery. Analytical Chemistry 94:4, pages 2032-2041.
Crossref
Crossref
Hui-Qing Chen, Jin-Yu Gong, Kai Xing, Mou-Ze Liu, Huan Ren & Jian-Quan Luo. (2022) Pharmacomicrobiomics: Exploiting the Drug-Microbiota Interactions in Antihypertensive Treatment. Frontiers in Medicine 8.
Crossref
Crossref
Xue Bai, Guiqin Liu, Jianxin Yang, Junbo Zhu & Xiangyang Li. (2022) Gut Microbiota as the Potential Mechanism to Mediate Drug Metabolism Under
High-altitude Hypoxia. Current Drug Metabolism 23:1, pages 8-20.
Crossref
Crossref
Rekha Jalandra, Ruby Dhar, Karthikeyan Pethusamy, Minakshi Sharma & Subhradip Karmakar. (2022) Dysbiosis: Gut feeling. F1000Research 11, pages 911.
Crossref
Crossref
Jiajia Zhou, Jian Ouyang, Zihao Gao, Haipeng Qin, Wu Jun & Tieliu Shi. (2022) MagMD: Database summarizing the metabolic action of gut microbiota to drugs. Computational and Structural Biotechnology Journal 20, pages 6427-6430.
Crossref
Crossref
Xin Zhou, Bowen Li, Mingming Guo, Wenchang Peng, Deping Wang, Qinglu Guo, Shuchao Wang, Dong Ming & Bin Zheng. (2022) Microneedle patch based on molecular motor as a spatio-temporal controllable dosing strategy of L-DOPA for Parkinson’s disease. Chemical Engineering Journal 427, pages 131555.
Crossref
Crossref
Tanshi Mehrotra & Subir Kumar Maulik. 2022. Human Microbiome in Health and Disease - Part A. Human Microbiome in Health and Disease - Part A
207
228
.
Aqsa Shahid, Sumreen Hayat, Samman Munir, Usman Ali Ashfaq, Abdul Arif Khan, Muhammad Bilal, Irfan Shaukat & Mohsin Khurshid. 2022. Biochemistry of Drug Metabolizing Enzymes. Biochemistry of Drug Metabolizing Enzymes
375
397
.
Faiza Abdur Rab & Azizul Hassan. 2022. Handbook of Technology Application in Tourism in Asia. Handbook of Technology Application in Tourism in Asia
1159
1200
.
Yusha Luo & Tingting Zhou. (2021) Connecting the dots: Targeting the microbiome in drug toxicity. Medicinal Research Reviews 42:1, pages 83-111.
Crossref
Crossref
G. V. Rukavishnikov, L. V. Leonova, E. D. Kasyanov, N. G. Neznanov & G. E. Mazo. (2021) The antidepressants effects on microbiota: unobvious possibilities Research article. V.M. BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY 57:4, pages 8-14.
Crossref
Crossref
Huanhuan Yan, Rui Su, Hongwei Xue, Chong Gao, Xiaofeng Li & Caihong Wang. (2021) Pharmacomicrobiology of Methotrexate in Rheumatoid Arthritis: Gut Microbiome as Predictor of Therapeutic Response. Frontiers in Immunology 12.
Crossref
Crossref
Vittoria Cella, Viviana M. Bimonte, Claudia Sabato, Antonio Paoli, Carlo Baldari, Matteo Campanella, Andrea Lenzi, Elisabetta Ferretti & Silvia Migliaccio. (2021) Nutrition and Physical Activity-Induced Changes in Gut Microbiota: Possible Implications for Human Health and Athletic Performance. Foods 10:12, pages 3075.
Crossref
Crossref
Joanna Nycz & Alicja Zajdel. (2021) Mikrobiota jelitowa a leki. Interakcje wpływające na skuteczność i bezpieczeństwo farmakoterapii. Postępy Higieny i Medycyny Doświadczalnej 75:1, pages 762-772.
Crossref
Crossref
José das Neves & Bruno Sarmento. 2021. Fundamentals of Drug Delivery. Fundamentals of Drug Delivery
471
506
.
Binyan Zhao, Bailing Zhou, Chunyan Dong, Rui Zhang, Daoyuan Xie, Yaomei Tian & Li Yang. (2021) Lactobacillus reuteri Alleviates Gastrointestinal Toxicity of Rituximab by Regulating the Proinflammatory T Cells in vivo. Frontiers in Microbiology 12.
Crossref
Crossref
Lavinia Curini & Amedeo Amedei. (2021) Cardiovascular Diseases and Pharmacomicrobiomics: A Perspective on Possible Treatment Relevance. Biomedicines 9:10, pages 1338.
Crossref
Crossref
Noora Alhajri, Rubiya Khursheed, Mohammad Taher Ali, Tareq Abu Izneid, Oumaima Al-Kabbani, Mahdia B. Al-Haidar, Fatima Al-Hemeiri, Mohamed Alhashmi & Faheem Hyder Pottoo. (2021) Cardiovascular Health and The Intestinal Microbial Ecosystem: The Impact of Cardiovascular Therapies on The Gut Microbiota. Microorganisms 9:10, pages 2013.
Crossref
Crossref
Magdalena Stojek, Anna Jabłońska & Krystian Adrych. (2021) The Role of Fecal Microbiota Transplantation in the Treatment of Inflammatory Bowel Disease. Journal of Clinical Medicine 10:18, pages 4055.
Crossref
Crossref
Haolin Zhang, Giovanni Caprioli, Hidayat Hussain, Nguyen Phan Khoi Le, Mohamed A. Farag & Jianbo Xiao. (2021) A multifaceted review on dihydromyricetin resources, extraction, bioavailability, biotransformation, bioactivities, and food applications with future perspectives to maximize its value. eFood 2:4, pages 164-184.
Crossref
Crossref
Md Masud Parvez, Abdul Basit, Parth B. Jariwala, Zsuzsanna Gáborik, Emese Kis, Scott Heyward, Matthew R. Redinbo & Bhagwat Prasad. (2021) Quantitative Investigation of Irinotecan Metabolism, Transport, and Gut Microbiome Activation. Drug Metabolism and Disposition 49:8, pages 683-693.
Crossref
Crossref
Koji Toma, Kanako Iwasaki, Geng Zhang, Kenta Iitani, Takahiro Arakawa, Yasuhiko Iwasaki & Kohji Mitsubayashi. (2021) Biochemical Methanol Gas Sensor (MeOH Bio-Sniffer) for Non-Invasive Assessment of Intestinal Flora from Breath Methanol. Sensors 21:14, pages 4897.
Crossref
Crossref
Zahari Vinarov, Mohammad Abdallah, José A.G. Agundez, Karel Allegaert, Abdul W. Basit, Marlies Braeckmans, Jens Ceulemans, Maura Corsetti, Brendan T. Griffin, Michael Grimm, Daniel Keszthelyi, Mirko Koziolek, Christine M. Madla, Christophe Matthys, Laura E. McCoubrey, Amitava Mitra, Christos Reppas, Jef Stappaerts, Nele Steenackers, Natalie L. Trevaskis, Tim Vanuytsel, Maria Vertzoni, Werner Weitschies, Clive Wilson & Patrick Augustijns. (2021) Impact of gastrointestinal tract variability on oral drug absorption and pharmacokinetics: An UNGAP review. European Journal of Pharmaceutical Sciences 162, pages 105812.
Crossref
Crossref
Julie Kristine Knudsen, Caspar Bundgaard‐Nielsen, Simon Hjerrild, René Ernst Nielsen, Peter Leutscher & Suzette Sørensen. (2021) Gut microbiota variations in patients diagnosed with major depressive disorder—A systematic review. Brain and Behavior 11:7.
Crossref
Crossref
Ryan A. Blaustein, Patrick C. Seed & Erica M. Hartmann. (2021) Biotransformation of Doxorubicin Promotes Resilience in Simplified Intestinal Microbial Communities. mSphere 6:3.
Crossref
Crossref
Guo-Ming Dong, Hang Yu, Li-Bin Pan, Shu-Rong Ma, Hui Xu, Zheng-Wei Zhang, Pei Han, Jie Fu, Xin-Yu Yang, Adili Keranmu, Hai-Tao Niu, Jian-Dong Jiang & Yan Wang. (2021) Biotransformation of Timosaponin BII into Seven Characteristic Metabolites by the Gut Microbiota. Molecules 26:13, pages 3861.
Crossref
Crossref
Rupjyoti Talukdar, Priyanka Sarkar, Aparna Jakkampudi, Subhaleena Sarkar, Mohsin Aslam, Manasa Jandhyala, G. Deepika, Misbah Unnisa & D. Nageshwar Reddy. (2021) The gut microbiome in pancreatogenic diabetes differs from that of Type 1 and Type 2 diabetes. Scientific Reports 11:1.
Crossref
Crossref
Lijun Wang, Weiwei Zhou, Manyun Guo, Yiming Hua, Baihua Zhou, Xinyin Li, Xinxin Zhang, Jiakun Dong, Xiumei Yang, Yang Wang, Yue Wu, Jianqing She & Jianjun Mu. (2021) The gut microbiota is associated with clinical response to statin treatment in patients with coronary artery disease. Atherosclerosis 325, pages 16-23.
Crossref
Crossref
Marilyn N. Martinez, Jonathan P. Mochel, Sibylle Neuhoff & Devendra Pade. (2021) Comparison of Canine and Human Physiological Factors: Understanding Interspecies Differences that Impact Drug Pharmacokinetics. The AAPS Journal 23:3.
Crossref
Crossref
Martina Franzin, Katja Stefančič, Marianna Lucafò, Giuliana Decorti & Gabriele Stocco. (2021) Microbiota and Drug Response in Inflammatory Bowel Disease. Pathogens 10:2, pages 211.
Crossref
Crossref
Anny Camelo-Castillo, José Miguel Rivera-Caravaca, Esteban Orenes-Piñero, Inmaculada Ramírez-Macías, Vanessa Roldán, Gregory Y. H. Lip & Francisco Marín. (2021) Gut Microbiota and the Quality of Oral Anticoagulation in Vitamin K Antagonists Users: A Review of Potential Implications. Journal of Clinical Medicine 10:4, pages 715.
Crossref
Crossref
Qin Yu, Christian Jobin & Ryan M. Thomas. (2021) Implications of the microbiome in the development and treatment of pancreatic cancer: Thinking outside of the box by looking inside the gut. Neoplasia 23:2, pages 246-256.
Crossref
Crossref
Tai Rao, Ya-ting Liu, Xiang-chang Zeng, Chao-peng Li & Dong-sheng Ou-Yang. (2020) The hepatotoxicity of Polygonum multiflorum: The emerging role of the immune-mediated liver injury. Acta Pharmacologica Sinica 42:1, pages 27-35.
Crossref
Crossref
Srinivasa Rao Vulichi, Kumar Rupak, Appa Rao Chippada, Durga Srinivasa Murthy Sistla, Venkata Rao Chunduri, Kapur Suman & Krishna Murthy Naidu Galla. 2021. Recent Developments in Applied Microbiology and Biochemistry. Recent Developments in Applied Microbiology and Biochemistry
89
101
.
L Jourová, B Lišková, K Lněničková, N Zemanová, P Anzenbacher, P Hermanová, T Hudcovic, H Kozáková & E Anzenbacherová. (2020) Presence or absence of microbiome modulates the response of mice organism to administered drug nabumetone. Physiological Research, pages 583-594.
Crossref
Crossref
Jiayu Sun, Fuya Zhao, Baiqiang Lin, Jing Feng, Xin Wu, Yang Liu, Lei Zhao, Biqiang Zhu & Yunwei Wei. (2020) Gut Microbiota Participates in Antithyroid Drug Induced Liver Injury Through the Lipopolysaccharide Related Signaling Pathway. Frontiers in Pharmacology 11.
Crossref
Crossref
Peter L. Miller & Tiffany L. Carson. (2020) Mechanisms and microbial influences on CTLA-4 and PD-1-based immunotherapy in the treatment of cancer: a narrative review. Gut Pathogens 12:1.
Crossref
Crossref
Sumeed Syed Manzoor, Annemiek Doedens & Michael B. Burns. (2020) The promise and challenge of cancer microbiome research. Genome Biology 21:1.
Crossref
Crossref
Nonglak Boonchooduang, Orawan Louthrenoo, Nipon Chattipakorn & Siriporn C. Chattipakorn. (2020) Possible links between gut–microbiota and attention-deficit/hyperactivity disorders in children and adolescents. European Journal of Nutrition 59:8, pages 3391-3403.
Crossref
Crossref
Katarzyna Tomela, Bernadeta Pietrzak, Marcin Schmidt & Andrzej Mackiewicz. (2020) The Tumor and Host Immune Signature, and the Gut Microbiota as Predictive Biomarkers for Immune Checkpoint Inhibitor Response in Melanoma Patients. Life 10:10, pages 219.
Crossref
Crossref
Damian Maseda & Emanuela Ricciotti. (2020) NSAID–Gut Microbiota Interactions. Frontiers in Pharmacology 11.
Crossref
Crossref
Stephanie A. Flowers, Shubha Bhat & James C. Lee. (2020) Potential Implications of Gut Microbiota in Drug Pharmacokinetics and Bioavailability. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 40:7, pages 704-712.
Crossref
Crossref
Alice Rouanet, Selin Bolca, Audrey Bru, Ingmar Claes, Helene Cvejic, Haymen Girgis, Ashton Harper, Sidonie N. Lavergne, Sophie Mathys, Marco Pane, Bruno Pot, Colette Shortt, Wynand Alkema, Constance Bezulowsky, Stephanie Blanquet-Diot, Christophe Chassard, Sandrine P. Claus, Benjamin Hadida, Charlotte Hemmingsen, Cyrille Jeune, Björn Lindman, Garikai Midzi, Luca Mogna, Charlotta Movitz, Nail Nasir, Manfred Oberreither, Jos F. M. L. Seegers, Luc Sterkman, Audrey Valo, Frédérique Vieville & Magali Cordaillat-Simmons. (2020) Live Biotherapeutic Products, A Road Map for Safety Assessment. Frontiers in Medicine 7.
Crossref
Crossref
Yong Zhang, Qiangchuan Hou, Chen Ma, Jie Zhao, Haiyan Xu, Weicheng Li, Yanjie Wang, Huimin Ma, Heping Zhang & Zhihong Sun. (2019) Lactobacillus casei protects dextran sodium sulfate- or rapamycin-induced colonic inflammation in the mouse. European Journal of Nutrition 59:4, pages 1443-1451.
Crossref
Crossref
Douglas L. Jennings, Bruno Bohn, Amelia Zuver, Duygu Onat, Maureen Gaine, Eugene Royzman, Jonathan Hupf, Danielle Brunjes, Farhana Latif, Susan Restaino, Arthur R. Garan, Veli K. Topkara, Hiroo Takayama, Koji Takeda, Yoshifumi Naka, Maryjane Farr, Renu Nandakumar, Anne-Catrin Uhlemann, Paolo C. Colombo, Ryan T. Demmer & Melana Yuzefpolskaya. (2020) Gut microbial diversity, inflammation, and oxidative stress are associated with tacrolimus dosing requirements early after heart transplantation. PLOS ONE 15:5, pages e0233646.
Crossref
Crossref
Cordula Stillhart, Katarina Vučićević, Patrick Augustijns, Abdul W. Basit, Hannah Batchelor, Talia R. Flanagan, Ina Gesquiere, Rick Greupink, Daniel Keszthelyi, Mikko Koskinen, Christine M. Madla, Christophe Matthys, Goran Miljuš, Miriam G. Mooij, Neil Parrott, Anna-Lena Ungell, Saskia N. de Wildt, Mine Orlu, Sandra Klein & Anette Müllertz. (2020) Impact of gastrointestinal physiology on drug absorption in special populations––An UNGAP review. European Journal of Pharmaceutical Sciences 147, pages 105280.
Crossref
Crossref
Matthew F. Peters, Allison L. Choy, Carmen Pin, Derek J. Leishman, Annie Moisan, Lorna Ewart, Peggy J. Guzzie-Peck, Radhakrishna Sura, Douglas A. Keller, Clay W Scott & Kyle L. Kolaja. (2020)
Developing
in vitro
assays to transform gastrointestinal safety assessment: potential for microphysiological systems
. Lab on a Chip 20:7, pages 1177-1190.
Crossref
Crossref
Yuemei Sun, Juanhong Zhang, Anpeng Zhao, Wenbin Li, Qiangsheng Feng & Rong Wang. (2020) Effects of intestinal flora on the pharmacokinetics and pharmacodynamics of aspirin in high-altitude hypoxia. PLOS ONE 15:3, pages e0230197.
Crossref
Crossref
Michael A. Malfatti, Edward A. Kuhn, Deepa K. Murugesh, Melanie E. Mendez, Nicholas Hum, James B. Thissen, Crystal J. Jaing & Gabriela G. Loots. (2020) Manipulation of the Gut Microbiome Alters Acetaminophen Biodisposition in Mice. Scientific Reports 10:1.
Crossref
Crossref
Xinyi Huang, Qing Fang, Tai Rao, Luping Zhou, Xiangchang Zeng, Zhirong Tan, Lulu Chen & Dongsheng Ouyang. (2020) Leucovorin ameliorated methotrexate induced intestinal toxicity via modulation of the gut microbiota. Toxicology and Applied Pharmacology 391, pages 114900.
Crossref
Crossref
Madhukar H. Trivedi, Cherise R. Chin Fatt, Manish K. Jha, Crystal M. Cooper, Joseph M. Trombello, Brittany L. Mason, Jennifer Hughes, Bharathi S. Gadad, Andrew H. Czysz, Russell T. Toll, Anne K. Fuller, Sangita Sethuram, Taryn L. Mayes, Abu Minhajuddin, Thomas Carmody & Tracy L. Greer. (2020) Comprehensive phenotyping of depression disease trajectory and risk: Rationale and design of Texas Resilience Against Depression study (T-RAD). Journal of Psychiatric Research 122, pages 22-32.
Crossref
Crossref
Nonkululeko H. Zuma, Frans J. Smit, Ronnett Seldon, Janine Aucamp, Audrey Jordaan, Digby F. Warner & David D. N'Da. (2020) Single-step synthesis and in vitro anti-mycobacterial activity of novel nitrofurantoin analogues. Bioorganic Chemistry 96, pages 103587.
Crossref
Crossref
Jeong Ill Suh. (2020) Drug-induced liver injury. Yeungnam University Journal of Medicine 37:1, pages 2-12.
Crossref
Crossref
Mariana Angoa-Pérez, Branislava Zagorac, Andrew D. Winters, Jonathan M. Greenberg, Madison Ahmad, Kevin R. Theis & Donald M. Kuhn. (2020) Differential effects of synthetic psychoactive cathinones and amphetamine stimulants on the gut microbiome in mice. PLOS ONE 15:1, pages e0227774.
Crossref
Crossref
Marie Lecronier, Parvine Tashk, Yanis Tamzali, Olivier Tenaillon, Erick Denamur, Benoit Barrou, Judith Aron-Wisnewsky & Jérôme Tourret. (2020) Gut microbiota composition alterations are associated with the onset of diabetes in kidney transplant recipients. PLOS ONE 15:1, pages e0227373.
Crossref
Crossref
Ilona Gorbovskaya, Sarah Kanji, Jonathan C.W. Liu, Nicole Elizabeth MacKenzie, Sri Mahavir Agarwal, Victoria S. Marshe, Venuja Sriretnakumar, Elena F. Verdu, Premysl Bercik, Giada De Palma, Margaret K. Hahn & Daniel J. Müller. (2020) Investigation of the Gut Microbiome in Patients with Schizophrenia and Clozapine-Induced Weight Gain: Protocol and Clinical Characteristics of First Patient Cohorts. Neuropsychobiology 79:1, pages 5-12.
Crossref
Crossref
Xiang Li, Linlin Liu, Zhiwen Cao, Wen Li, Hui Li, Cheng Lu, Xueqin Yang & Yuanyan Liu. (2020) Gut microbiota as an “invisible organ” that modulates the function of drugs. Biomedicine & Pharmacotherapy 121, pages 109653.
Crossref
Crossref
Samantha M. Ervin, Ronan P. Hanley, Lauren Lim, William G. Walton, Kenneth H. Pearce, Aadra P. Bhatt, Lindsey I. James & Matthew R. Redinbo. (2019) Targeting Regorafenib-Induced Toxicity through Inhibition of Gut Microbial β-Glucuronidases. ACS Chemical Biology 14:12, pages 2737-2744.
Crossref
Crossref
Yicheng Wang, Gang Yang, Lei You, Jinshou Yang, Mengyu Feng, Jiangdong Qiu, Fangyu Zhao, Yueze Liu, Zhe Cao, Lianfang Zheng, Taiping Zhang & Yupei Zhao. (2019) Role of the microbiome in occurrence, development and treatment of pancreatic cancer. Molecular Cancer 18:1.
Crossref
Crossref
Rajeev K Azad & Vladimir Shulaev. (2019) Metabolomics technology and bioinformatics for precision medicine. Briefings in Bioinformatics 20:6, pages 1957-1971.
Crossref
Crossref
Emmanuel Biver, Francis Berenbaum, Ana M. Valdes, Islene Araujo de Carvalho, Laure B. Bindels, Maria Luisa Brandi, Philip C. Calder, Vincenzo Castronovo, Etienne Cavalier, Antonio Cherubini, Cyrus Cooper, Elaine Dennison, Claudio Franceschi, Nicholas Fuggle, Andrea Laslop, Pierre Miossec, Thierry Thomas, Sansin Tuzun, Nicola Veronese, Mila Vlaskovska, Jean-Yves Reginster & René Rizzoli. (2019) Gut microbiota and osteoarthritis management: An expert consensus of the European society for clinical and economic aspects of osteoporosis, osteoarthritis and musculoskeletal diseases (ESCEO). Ageing Research Reviews 55, pages 100946.
Crossref
Crossref
Chaoheng Yu, Bailing Zhou, Xuyang Xia, Shuang Chen, Yun Deng, Yantai Wang, Lei Wu, Yaomei Tian, Binyan Zhao, Heng Xu & Li Yang. (2019) Prevotella copri is associated with carboplatin-induced gut toxicity. Cell Death & Disease 10:10.
Crossref
Crossref
Cristina Stasi, Sinan Sadalla & Stefano Milani. (2019) The Relationship Between the Serotonin Metabolism, Gut-Microbiota and the Gut-Brain Axis. Current Drug Metabolism 20:8, pages 646-655.
Crossref
Crossref
Yalda Hekmatshoar, Yalda Rahbar Saadat, Seyed Mahdi Hosseiniyan Khatibi, Tulin Ozkan, Fatemeh Zununi Vahed, Ziba Nariman-Saleh-Fam, Bahram Pourghassem Gargari, Asuman Sunguroglu & Sepideh Zununi Vahed. (2019) The impact of tumor and gut microbiotas on cancer therapy: Beneficial or detrimental?. Life Sciences 233, pages 116680.
Crossref
Crossref
Yang Li, Ying Peng, Ping Ma, Mengyue Wang, Chongsheng Peng, Pengfei Tu & Xiaobo Li. (2019) In vitro and in vivo metabolism of Cistanche tubulosa extract in normal and chronic unpredictable stress-induced depressive rats. Journal of Chromatography B 1125, pages 121728.
Crossref
Crossref
Luya Li, Xue Feng, Yuting Chen, Shenghao Li, Yupeng Sun & Lantong Zhang. (2019)
A comprehensive study of eriocitrin metabolism
in vivo
and
in vitro
based on an efficient UHPLC-Q-TOF-MS/MS strategy
. RSC Advances 9:43, pages 24963-24980.
Crossref
Crossref
Nataliya Mar & Farshid Dayyani. (2019) Management of Urothelial Bladder Cancer in Clinical Practice: Real-World Answers to Difficult Questions. Journal of Oncology Practice 15:8, pages 421-428.
Crossref
Crossref
Eleonore Fröhlich & Richard Wahl. (2019) Microbiota and Thyroid Interaction in Health and Disease. Trends in Endocrinology & Metabolism 30:8, pages 479-490.
Crossref
Crossref
Anukriti Sharma, Mary M. Buschmann & Jack A. Gilbert. (2019) Pharmacomicrobiomics: The Holy Grail to Variability in Drug Response?. Clinical Pharmacology & Therapeutics 106:2, pages 317-328.
Crossref
Crossref
Luya Li, Yuting Chen, Xue Feng, Jintuo Yin, Shenghao Li, Yupeng Sun & Lantong Zhang. (2019) Identification of Metabolites of Eupatorin in Vivo and in Vitro Based on UHPLC-Q-TOF-MS/MS. Molecules 24:14, pages 2658.
Crossref
Crossref
Campesi, Romani & Franconi. (2019) The Sex–Gender Effects in the Road to Tailored Botanicals. Nutrients 11:7, pages 1637.
Crossref
Crossref
Jing Cong, Jingjuan Zhu, Chuantao Zhang, Tianjun Li, Kewei Liu, Dong Liu, Na Zhou, Man Jiang, Helei Hou & Xiaochun Zhang. (2019) Chemotherapy Alters the Phylogenetic Molecular Ecological Networks of Intestinal Microbial Communities. Frontiers in Microbiology 10.
Crossref
Crossref
Sofia Cussotto, Gerard Clarke, Timothy G. Dinan & John F. Cryan. (2019) Psychotropics and the Microbiome: a Chamber of Secrets…. Psychopharmacology 236:5, pages 1411-1432.
Crossref
Crossref
D. Beltrán, M. D. Frutos-Lisón, J. C. Espín & R. García-Villalba. (2019) Re-examining the role of the gut microbiota in the conversion of the lipid-lowering statin monacolin K (lovastatin) into its active β-hydroxy acid metabolite. Food & Function 10:4, pages 1787-1791.
Crossref
Crossref
Mahesh Raj Nepal, Ki Sun Jeong, Geon Ho Kim, Dong Ho Cha, Mi Jeong Kang, Jin Sung Kim, Ju-Hyun Kim & Tae Cheon Jeong. (2019) Role of Intestinal Microbiota in Metabolism of Gastrodin In Vitro and In Vivo. Metabolites 9:4, pages 69.
Crossref
Crossref
Wuwen Feng, Hui Ao, Cheng Peng & Dan Yan. (2019) Gut microbiota, a new frontier to understand traditional Chinese medicines. Pharmacological Research 142, pages 176-191.
Crossref
Crossref
Bernhard Englinger, Christine Pirker, Petra Heffeter, Alessio Terenzi, Christian R. Kowol, Bernhard K. Keppler & Walter Berger. (2018) Metal Drugs and the Anticancer Immune Response. Chemical Reviews 119:2, pages 1519-1624.
Crossref
Crossref
AnaghaVishwas Ranade, Amey Shirolkar & SharadDaulatrao Pawar. (2019) Gut microbiota: One of the new frontiers for elucidating fundamentals of Vipaka in Ayurveda. AYU (An international quarterly journal of research in Ayurveda) 40:2, pages 75.
Crossref
Crossref
Jin Wang, Li Shao, Tai Rao, Wei Zhang & Wei-Hua Huang. (2019)
Chemo-Preventive Potential of Falcarindiol-Enriched Fraction from
Oplopanax elatus
on Colorectal Cancer Interfered by Human Gut Microbiota
. The American Journal of Chinese Medicine 47:06, pages 1381-1404.
Crossref
Crossref
Elaine Holmes, Ian D. Wilson & John C. Lindon. 2019. The Handbook of Metabolic Phenotyping. The Handbook of Metabolic Phenotyping
1
51
.
Gabrielle King, Kathryn D. Baker, Madelyne A. Bisby, Diana Chan, Caitlin S. M. Cowan, Anthea A. Stylianakis, Kelsey S. Zimmermann & Rick Richardson. (2018) A precision medicine approach to pharmacological adjuncts to extinction: a call to broaden research. Psychopharmacology 236:1, pages 143-161.
Crossref
Crossref
Jurica Zucko, Antonio Starcevic, Janko Diminic & Damir Oros. 2019. Personalized Medicine in Healthcare Systems. Personalized Medicine in Healthcare Systems
107
120
.
Edward E. K. Baidoo & Veronica Teixeira Benites. 2019. Microbial Metabolomics. Microbial Metabolomics
11
69
.
Aarti Sawant-Basak, A. David Rodrigues, Matthew Lech, Regis Doyonnas, Marion Kasaian, Bhagwat Prasad & Nikolaos Tsamandouras. (2018) Physiologically Relevant, Humanized Intestinal Systems to Study Metabolism and Transport of Small Molecule Therapeutics. Drug Metabolism and Disposition 46:11, pages 1581-1587.
Crossref
Crossref
Leonard A. Valentino, Peter L. Turecek, Herbert Gritsch, Saulius Butenas & Kenneth G. Mann. (2018) Issues complicating precision dosing for factor VIII prophylaxis. Transfusion and Apheresis Science 57:4, pages 472-479.
Crossref
Crossref
Kemin Tan, Christine Tesar, Rosemarie Wilton, Robert P. Jedrzejczak & Andrzej Joachimiak. (2018) Interaction of antidiabetic α-glucosidase inhibitors and gut bacteria α-glucosidase. Protein Science 27:8, pages 1498-1508.
Crossref
Crossref
Elaine F. Enright, Brendan T. Griffin, Cormac G.M. Gahan & Susan A. Joyce. (2018) Microbiome-mediated bile acid modification: Role in intestinal drug absorption and metabolism. Pharmacological Research 133, pages 170-186.
Crossref
Crossref
Min Sun Choi, Jun Sang Yu, Hye Hyun Yoo & Dong-Hyun Kim. (2018) The role of gut microbiota in the pharmacokinetics of antihypertensive drugs. Pharmacological Research 130, pages 164-171.
Crossref
Crossref
Juan Antonio Gimenez-Bastida, Lucia Martinez Carreras, Angela Moya-Pérez & José Moisés Laparra Llopis. (2018) Pharmacological Efficacy/Toxicity of Drugs: A Comprehensive Update About the Dynamic Interplay of Microbes. Journal of Pharmaceutical Sciences 107:3, pages 778-784.
Crossref
Crossref
Austin Yan, Elizabeth Culp, Julie Perry, Jennifer T. Lau, Lesley T. MacNeil, Michael G. Surette & Gerard D. Wright. (2017) Transformation of the Anticancer Drug Doxorubicin in the Human Gut Microbiome. ACS Infectious Diseases 4:1, pages 68-76.
Crossref
Crossref
D. Fillman-Holliday & J. Everitt. 2018. Comprehensive Toxicology. Comprehensive Toxicology
75
94
.
Moira Marizzoni, Stefania Provasi, Annamaria Cattaneo & Giovanni B. Frisoni. (2017) Microbiota and neurodegenerative diseases. Current Opinion in Neurology 30:6, pages 630-638.
Crossref
Crossref
Keumhan Noh, You Ra Kang, Mahesh Raj Nepal, Rajina Shakya, Mi Jeong Kang, Wonku Kang, Sangkyu Lee, Hye Gwang Jeong & Tae Cheon Jeong. (2017) Impact of gut microbiota on drug metabolism: an update for safe and effective use of drugs. Archives of Pharmacal Research 40:12, pages 1345-1355.
Crossref
Crossref
Yuanyan Liu, Sensen Chi, Weihua Wang, Lei Su & Bin Liu. (2017) Simultaneous Determination of Seven Components in Rat Plasma by the UPLC-MS/MS Method and Application of Pharmacokinetic Studies to SimiaoYong’an Decoction. Molecules 22:11, pages 1937.
Crossref
Crossref
Ksenia J. Groh, Birgit Geueke & Jane Muncke. (2017) Food contact materials and gut health: Implications for toxicity assessment and relevance of high molecular weight migrants. Food and Chemical Toxicology 109, pages 1-18.
Crossref
Crossref
Ashok K. Sharma, Shubham K. Jaiswal, Nikhil Chaudhary & Vineet K. Sharma. (2017) A novel approach for the prediction of species-specific biotransformation of xenobiotic/drug molecules by the human gut microbiota. Scientific Reports 7:1.
Crossref
Crossref
Yisong Shu, Zhenli Liu, Siyu Zhao, Zhiqian Song, Dan He, Menglei Wang, Honglian Zeng, Cheng Lu, Aiping Lu & Yuanyan Liu. (2017) Integrated and global pseudotargeted metabolomics strategy applied to screening for quality control markers of Citrus TCMs. Analytical and Bioanalytical Chemistry 409:20, pages 4849-4865.
Crossref
Crossref
Angela Ladurner, Martin Zehl, Ulrike Grienke, Christoph Hofstadler, Nadina Faur, Fátima C. Pereira, David Berry, Verena M. Dirsch & Judith M. Rollinger. (2017) Allspice and Clove As Source of Triterpene Acids Activating the G Protein-Coupled Bile Acid Receptor TGR5. Frontiers in Pharmacology 8.
Crossref
Crossref
James L. Alexander, Ian D. Wilson, Julian Teare, Julian R. Marchesi, Jeremy K. Nicholson & James M. Kinross. (2017) Gut microbiota modulation of chemotherapy efficacy and toxicity. Nature Reviews Gastroenterology & Hepatology 14:6, pages 356-365.
Crossref
Crossref
R.H. Waring, R.M. Harris & S.C. Mitchell. (2017) Drug metabolism in the elderly: A multifactorial problem?. Maturitas 100, pages 27-32.
Crossref
Crossref
Xuyun He, Ningning Zheng, Jiaojiao He, Can Liu, Jing Feng, Wei Jia & Houkai Li. (2017) Gut Microbiota Modulation Attenuated the Hypolipidemic Effect of Simvastatin in High-Fat/Cholesterol-Diet Fed Mice. Journal of Proteome Research 16:5, pages 1900-1910.
Crossref
Crossref
Nancy J. Ames, Alexandra Ranucci, Brad Moriyama & Gwenyth R. Wallen. (2017) The Human Microbiome and Understanding the 16S rRNA Gene in Translational Nursing Science. Nursing Research 66:2, pages 184-197.
Crossref
Crossref
Rodney R. Dietert. (2017) The microbiome-immune-host defense barrier complex (microimmunosome) and developmental programming of noncommunicable diseases. Reproductive Toxicology 68, pages 49-58.
Crossref
Crossref
Pengcheng Wang, Amina I. Shehu & Xiaochao Ma. (2017) The Opportunities of Metabolomics in Drug Safety Evaluation. Current Pharmacology Reports 3:1, pages 10-15.
Crossref
Crossref
Emily Grace Armitage & Michal Ciborowski. 2017. Metabolomics: From Fundamentals to Clinical Applications. Metabolomics: From Fundamentals to Clinical Applications
209
234
.
Robert G. Nichols, Nicole E. Hume, Philip B. Smith, Jeffrey M. Peters & Andrew D. Patterson. (2016) Omics Approaches To Probe Microbiota and Drug Metabolism Interactions. Chemical Research in Toxicology 29:12, pages 1987-1997.
Crossref
Crossref
Lenka Jourova, Pavel Anzenbacher & Eva Anzenbacherova. (2016) Human gut microbiota plays a role in the metabolism of drugs. Biomedical Papers 160:3, pages 317-326.
Crossref
Crossref
Sarah Louise Morland, Karen J.B. Martins & Vera C. Mazurak. (2016) n-3 polyunsaturated fatty acid supplementation during cancer chemotherapy. Journal of Nutrition & Intermediary Metabolism 5, pages 107-116.
Crossref
Crossref
Emily G. Armitage & Andrew D. Southam. (2016) Monitoring cancer prognosis, diagnosis and treatment efficacy using metabolomics and lipidomics. Metabolomics 12:9.
Crossref
Crossref
Susan L. Prescott, Rachel A. Millstein, Martin A. Katzman & Alan C. Logan. (2016) Biodiversity, the Human Microbiome and Mental Health: Moving toward a New Clinical Ecology for the 21st Century?. International Journal of Biodiversity 2016, pages 1-18.
Crossref
Crossref